open targets Archives

2 June 2023

ProtVar: understanding missense variation in humans

Science, Technology and innovation A new tool for the interpretation of missense variation in humans – ProtVar – will help enable drug discovery.

2023

sciencetechnology-and-innovation

27 February 2023 Protein interactome

A human interactome to prioritise drug discovery

Research highlights, Science Researchers create a network of interacting proteins – or interactome – to aid drug discovery.

2023

research-highlightsscience

26 January 2023 The final set of nodes in a machine learning neural network connect to the first atom of a simplified chemical structure

Machine learning to identify and prioritise drug targets

Science, Technology and innovation Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.

2023

sciencetechnology-and-innovation

11 November 2022 Open Targets logo

Open Targets consortium welcomes Genentech as newest member

Announcements, Science Open Targets announces that Genentech will become the seventh partner in the drug discovery and validation consortium.

2022

announcementsscience

10 February 2022 Pfizer logo with pipette tips in the background

Pfizer joins the Open Targets consortium

Announcements, Science Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.

2022

announcementsscience

19 October 2021 Male person sitting at a desk with computer and papers, looking at the camera.

The human genome, data sharing, and drug discovery: a career profile with Ian Dunham

Lab Matters Ian Dunham walks us through his career so far including working on the human genome project, seeing his work on the cover of Nature and his current role as Director of Open Targets.

2021

lab-matters

21 July 2021 Proteasome targeting unwanted proteins.